Literature DB >> 14963162

Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine.

Udaykumar Ranga1, Raj Shankarappa, Nagadenahalli B Siddappa, Lakshmi Ramakrishna, Ramalingam Nagendran, Marthandan Mahalingam, Anita Mahadevan, Narayana Jayasuryan, Parthasarathy Satishchandra, Susarla K Shankar, Vinayaka R Prasad.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-associated dementia (HAD) is correlated with increased monocyte migration to the brain, and the incidence of HAD among otherwise asymptomatic subjects appears to be lower in India than in the United States and Europe (1 to 2% versus 15 to 30%). Because of the genetic differences between HIV-1 strains circulating in these regions, we sought to identify viral determinants associated with this difference. We targeted Tat protein for these studies in view of its association with monocyte chemotactic function. Analyses of Tat sequences representing nine subtypes revealed that at least six amino acid residues are differentially conserved in subtype C Tat (C-Tat). Of these, cysteine (at position 31) was highly (>99%) conserved in non-subtype C viruses and more than 90% of subtype C viruses encoded a serine. We hypothesized a compromised chemotactic function of C-Tat due to the disruption of CC motif and tested it with the wild type C-Tat (CS) and its two isogenic variants (CC and SC) derived by site-directed mutagenesis. We found that the CS natural variant was defective for monocyte chemotactic activity without a loss in the transactivation property. While the CC mutant is functionally competent for both the functions, in contrast, the SC mutant was defective in both. Therefore, the loss of the C-Tat chemotactic property may underlie the reduced incidence of HAD; although not presenting conclusive evidence, this study provides the first evidence for a potential epidemiologic phenomenon associated with biological differences in the subtype C viruses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963162      PMCID: PMC369202          DOI: 10.1128/jvi.78.5.2586-2590.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Accelerating the development and future availability of HIV-1 vaccines: why, when, where, and how?

Authors:  J Esparza; N Bhamarapravati
Journal:  Lancet       Date:  2000-06-10       Impact factor: 79.321

Review 2.  Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. The HNRC Group. HIV Neurobehavioral Research Center.

Authors:  D A White; R K Heaton; A U Monsch
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

3.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

4.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

5.  Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: a new surveillance tool for molecular epidemiology.

Authors:  S Cassol; B G Weniger; P G Babu; M O Salminen; X Zheng; M T Htoon; A Delaney; M O'Shaughnessy; C Y Ou
Journal:  AIDS Res Hum Retroviruses       Date:  1996-10-10       Impact factor: 2.205

Review 6.  Chemokines.

Authors:  B J Rollins
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

7.  The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center.

Authors:  R K Heaton; I Grant; N Butters; D A White; D Kirson; J H Atkinson; J A McCutchan; M J Taylor; M D Kelly; R J Ellis
Journal:  J Int Neuropsychol Soc       Date:  1995-05       Impact factor: 2.892

Review 8.  Human immunodeficiency viruses in the developing world.

Authors:  M Essex
Journal:  Adv Virus Res       Date:  1999       Impact factor: 9.937

9.  Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96).

Authors:  P Satishchandra; A Nalini; M Gourie-Devi; N Khanna; V Santosh; V Ravi; A Desai; A Chandramuki; P N Jayakumar; S K Shankar
Journal:  Indian J Med Res       Date:  2000-01       Impact factor: 2.375

10.  HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes.

Authors:  R M Lafrenie; L M Wahl; J S Epstein; I K Hewlett; K M Yamada; S Dhawan
Journal:  J Immunol       Date:  1996-08-01       Impact factor: 5.422

View more
  87 in total

1.  Impact of the HIV Tat C30C31S dicysteine substitution on neuropsychological function in patients with clade C disease.

Authors:  Robert H Paul; John A Joska; Carol Woods; Soraya Seedat; Susan Engelbrecht; Jacqueline Hoare; Jodi Heaps; Victor Valcour; Beau Ances; Laurie M Baker; Lauren E Salminen; Dan J Stein
Journal:  J Neurovirol       Date:  2014-11-01       Impact factor: 2.643

2.  Genetic characterization of HIV type 1 Tat exon 1 from a southern Indian clinical cohort: identification of unique epidemiological signature residues.

Authors:  Ujjwal Neogi; Soham Gupta; Pravat Nalini Sahoo; Anita Shet; Shwetha D Rao; Udaykumar Ranga; Vinayaka R Prasad
Journal:  AIDS Res Hum Retroviruses       Date:  2012-05-02       Impact factor: 2.205

3.  HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children.

Authors:  Michael J Boivin; Theodore D Ruel; Hannah E Boal; Paul Bangirana; Huyen Cao; Leigh A Eller; Edwin Charlebois; Diane V Havlir; Moses R Kamya; Jane Achan; Carolyne Akello; Joseph K Wong
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

4.  Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts.

Authors:  Theodore D Ruel; Michael J Boivin; Hannah E Boal; Paul Bangirana; Edwin Charlebois; Diane V Havlir; Philip J Rosenthal; Grant Dorsey; Jane Achan; Carolyne Akello; Moses R Kamya; Joseph K Wong
Journal:  Clin Infect Dis       Date:  2012-02-04       Impact factor: 9.079

5.  The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.

Authors:  Shambhu Prasad G Aralaguppe; Shilpee Sharma; Malini Menon; Vinayaka R Prasad; Shanmugam Saravanan; Kailapuri G Murugavel; Suniti Solomon; Udaykumar Ranga
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-09       Impact factor: 2.205

6.  Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil.

Authors:  Sergio Monteiro de Almeida; Francisco Jaime Barbosa; Rujvi Kamat; Ana Paula de Pereira; Sonia Mara Raboni; Indianara Rotta; Clea Elisa Ribeiro; Mariana Cherner; Ronald J Ellis; Joseph Hampton Atkinson
Journal:  J Neurovirol       Date:  2016-07-18       Impact factor: 2.643

7.  Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.

Authors:  Yujie Liu; Michael R Nonnemacher; Devin L Stauff; Luna Li; Anupam Banerjee; Bryan Irish; Evelyn Kilareski; Nirmala Rajagopalan; Joyce B Suchitra; Zafar K Khan; Udaykumar Ranga; Brian Wigdahl
Journal:  Biomed Pharmacother       Date:  2010-09-25       Impact factor: 6.529

8.  Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.

Authors:  Grant R Campbell; Jennifer D Watkins; Erwann P Loret; Stephen A Spector
Journal:  AIDS Res Hum Retroviruses       Date:  2010-12-07       Impact factor: 2.205

Review 9.  NeuroAIDS in Brazil.

Authors:  Ronald J Ellis; Jeymohan Joseph; Ségio Montiero de Almeida
Journal:  J Neurovirol       Date:  2007-04       Impact factor: 2.643

10.  Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.

Authors:  Wadchara Pumpradit; Jintanat Ananworanich; Sermsak Lolak; Cecilia Shikuma; Robert Paul; Umaporn Siangphoe; Nithima Chaoniti; Peeraporn Kaew-On; Robert Paris; Kiat Ruxrungtham; Victor Valcour
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.